Contact
Please use this form to send email to PR contact of this press release:
GSK announces approval in Canada for Incruse Ellipta (umeclidinium) as a treatment for COPD
TO:
Please use this form to send email to PR contact of this press release:
GSK announces approval in Canada for Incruse Ellipta (umeclidinium) as a treatment for COPD
TO: